Skip to content

Clinical trials

Completed Leukemia, Myeloid, Chronic-Phase trials with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myeloid, Chronic-Phase Phase: Not applicable Status: Completed Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20023
20034
20043
20051
20062
20071
20091
20102
20151
20202

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed27

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fred Hutchinson Cancer Center5
Roswell Park Cancer Institute3
Wake Forest University Health Sciences3
City of Hope Medical Center2
University of California, San Francisco2
Asan Medical Center1
Barbara Ann Karmanos Cancer Institute1
Case Comprehensive Cancer Center1
H. Lee Moffitt Cancer Center and Research Institute1
Jonsson Comprehensive Cancer Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myeloid, Chronic-Phase27
Precursor Cell Lymphoblastic Leukemia-Lymphoma24
Burkitt Lymphoma23
Leukemia, Lymphocytic, Chronic, B-Cell23
Leukemia, Myeloid, Accelerated Phase23
Lymphoma, Follicular23
Lymphoma, Large B-Cell, Diffuse23
Lymphoma, Non-Hodgkin23
Lymphoma, B-Cell, Marginal Zone22
Lymphoma, Large-Cell, Immunoblastic22

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.